shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > Mumbai > Mumbai News > Article > Israel India collaborate to enhance healthcare with advanced antimicrobial emergency room at JJ hospital in Mumbai

Israel-India collaborate to enhance healthcare with advanced antimicrobial emergency room at JJ hospital in Mumbai

Updated on: 28 August,2024 05:33 PM IST  |  Mumbai
A Correspondent |

Col. (Res) Yaakov Blitshtein, Israel's Director General of Foreign Affairs on Wednesday inaugurated a state-of-the-art emergency room at the JJ Hospital

Israel-India collaborate to enhance healthcare with advanced antimicrobial emergency room at JJ hospital in Mumbai

JJ Hospital. File Pic

Israel and India on Wednesday collaborated to enhance healthcare system in Mumbai with the launch of advanced antimicrobial emergency room at JJ Hospital in Mumbai.


Col. (Res) Yaakov Blitshtein, Israel's Director General of Foreign Affairs on Wednesday inaugurated a state-of-the-art emergency room at the JJ Hospital, marking a major improvement in medical technology, an official statement said.


It said that the launch of advanced antimicrobial emergency room Technology demonstrates the fruitful partnership between Israel and India to enhance infection control and patient safety.


"The newly inaugurated emergency room features advanced antimicrobial acrylic paint developed by the Israeli deep-tech company Nanosono, in partnership with Nirlat. The pioneering paint, branded as QUACTIV, offers a revolutionary solution for infection control by eliminating up to 99.99% of bacteria, viruses, and moulds within hours. Its continuous protection against harmful microorganisms is achieved without toxic substances, making it an environmentally friendly and safe option for maintaining a sterile environment," the statement said.

Col. (Res) Yaakov Blitshtein expressed his enthusiasm for the project, stating, "The launch of this advanced antimicrobial emergency room at JJ Hospital represents a crucial milestone in the collaboration between Israel and India. It reflects our commitment to leveraging Israeli technological advancements to enhance patient safety and public health in India," it said.

It marks a significant milestone in integrating Israeli innovation with India's advanced healthcare infrastructure.

During the event, Kobbi Shoshani, Consul General of Israel to Mumbai, highlighted the importance of the India-Israel partnership and said, "This cooperation signifies a transformative leap in the medical sector, merging India’s advanced healthcare system with Israel’s expertise in specialty chemicals. It represents a profound partnership, setting a new benchmark in medical innovation that will positively impact healthcare practices in both countries," the statement further stated.

Dr. Pallavi Saple, Dean of JJ Hospital, underscored the importance of adopting such cutting-edge technology. 

She said, "The implementation of QUACTIV™️ antimicrobial paint is a major step forward for JJ Hospital. This technology provides an essential additional layer of protection for our patients, crucial for preventing infections and ensuring a safe environment."

Meanwhile, Ori Bar Chaim, CEO of Nanosono also highlighted the broader implications of the new breakthrough.

He said, "QUACTIV sets new safety standards in healthcare environments and beyond. We are excited to witness its positive impact in India and look forward to further expanding its applications."

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK